review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/0304-3959(77)90083-5 |
P953 | full work available at URL | https://journals.lww.com/10.1016/0304-3959(77)90083-5 |
P698 | PubMed publication ID | 22060 |
P2093 | author name string | Loy D. Lytle | |
Rita B. Messing | |||
P2860 | cites work | A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine | Q28242467 |
Serotonin nerve terminals in adult rat neocortex | Q30828991 | ||
Antagonism of Stimulation-Produced Analgesia by Naloxone, a Narcotic Antagonist | Q34168553 | ||
Opiate Receptor: Demonstration in Nervous Tissue | Q34216480 | ||
Analgesia from Electrical Stimulation in the Brainstem of the Rat | Q34229438 | ||
Some thoughts on the significance of enkephalin, the endogenous ligand | Q34662541 | ||
Behavioral correlates of serotonin depletion | Q35042388 | ||
Control of brain neurotransmitter synthesis by precursor availability and nutritional state | Q39106359 | ||
p -Chloroamphetamine: Selective Neurotoxic Action in Brain | Q39319613 | ||
Axonal transport in serotonin neurons of the midbrain raphe | Q39379818 | ||
Response to electric shock in rats: Effects of selective midbrain raphe lesions | Q39733156 | ||
Influence of L-tryptophan on morphine analgesia, tolerance and physical dependence | Q39734488 | ||
Monoaminergic mechanisms of stimulation-produced analgesia | Q39738284 | ||
Interaction of diet and drugs in the regulation of brain 5-hydroxyindoles and the response to painful electric shock | Q39766676 | ||
Antinociceptive action of oxotremorine and regional turnover of rat brain noradrenaline, dopamine and 5-HT | Q40332382 | ||
Reversal of morphine and stimulus-produced analgesia by subtotal spinal cord lesions | Q41054440 | ||
The effect of biogenic amine modifiers on morphine analgesia and its antagonism by naloxone | Q42084425 | ||
Morphine Action at Central Nervous System Sites in Rat: Analgesia or Hyperalgesia Depending on Site and Dose | Q42233609 | ||
Effects of 5-hydroxytryptamine and bradykinin in cat dorsal horn neurones activated by noxious stimuli | Q43465139 | ||
Effects of rho-chloroamphetamine on locomotor activity and brain 5-hydroxyindoles | Q43490140 | ||
Stimulation-produced Analgesia: Development of Tolerance and Cross-Tolerance to Morphine | Q43516135 | ||
Ascending catecholamine systems and morphine analgesia | Q43625207 | ||
Anatomical specificity as the critical determinant of the interrelationship between raphe lesions and morphine analgesia | Q43844632 | ||
Effects of long-term corn consumption on brain serotonin and the response to electric shock | Q43999914 | ||
Lesions in the nuclei accumbens septi of the rat: Behavioral and neurochemical effects | Q44049596 | ||
Antagonism by methysergide and cinanserin of the antinociceptive action of morphine administered into the periaqueductal gray | Q48397468 | ||
Behavioral effects of L-5-hydroxytryptophan after destruction of ascending serotonergic pathways in the rat: the role of catecholaminergic neurons | Q48404087 | ||
Morphine analgesia: Blockade by raphe magnus lesions | Q48429694 | ||
Acute effects of heroin and morphine on newly synthesized serotonin in rat brain | Q48447722 | ||
Differential effects on morphine analgesia and naloxone antagonism by biogenic amine modifiers | Q48452700 | ||
The influence of raphe lesions on the effect of morphine on nociception and cortical ACh output | Q48467411 | ||
Unchanged sensitivity to electric shock in L-tryptophan treated rats | Q48471812 | ||
Effect of acutely administered analgesic drugs on rat brain serotonin turnover | Q48501613 | ||
Sites of morphine induced analgesia in the primate brain: relation to pain pathways | Q48506616 | ||
Differential behavioral and neurochemical effects following lesions of the dorsal or median raphe nuclei in rats | Q48513450 | ||
Paradoxical Effects after Microinjection of Morphine in the Periaqueductal Gray Matter in the Rat | Q48521313 | ||
Analgesia and hyperreactivity produced by intracranial microinjections of morphine into the periaqueductal gray matter of the rat. | Q48545181 | ||
Behavioral and electrophysiological evidence of pain inhibition from midbrain stimulation in the cat | Q48562722 | ||
Pain reduction by focal electrical stimulation of the brain: An anatomical and behavioral analysis | Q48571431 | ||
Morphine analgesia, two-way avoidance, and consummatory behavior following lesions in the midbrain raphe nuclei of the rat | Q48573550 | ||
Long-term effects of 5,7-dihydroxytryptamine on brain monoamines | Q48573801 | ||
Does 5-hydroxytryptamine influence cholinergic mechanisms in the central nervous system? | Q48606096 | ||
Effect of thymoleptics on fenfluramine-induced depletion of brain serotonin in rats | Q48620705 | ||
Modification of serotonin metabolism in rat brain after acute or chronic administration of morphine | Q48620808 | ||
Effect of lesions in the medial forebrain bundle on three measures of pain sensitivity and noise-elicited startle. | Q48662886 | ||
Evidence for the synthesis and storage of 5-hydroxytryptamine in two separate pools in the brain | Q48674803 | ||
Central monoamines and antinociceptive drug action | Q48719045 | ||
Antagonism of stimulation-produced analgesia by p-CPA, a serotonin synthesis inhibitor | Q48726529 | ||
The effects of cyproheptadine, methysergide, BC 105 and reserpine on brain 5-hydroxytryptamine and brain growth | Q48736589 | ||
Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition | Q48752150 | ||
Lesions in the medial forebrain bundle: relationship between pain sensitivity and telencephalic content of serotonin. | Q48874370 | ||
Release of [3H]serotonin from brain slices | Q49043240 | ||
Altered sensitivity to footshock and decreased brain content of serotonin following brain lesions in the rat | Q49080445 | ||
The effects of precursor loading in the cerebral metabolism of 5-hydroxyindoles | Q49142899 | ||
5,7-Dihydroxytryptamine: Improvement in chemical lesioning of indoleamine neurons in the mammalian brain | Q51110212 | ||
Effect of Chronic Corn Consumption on Serotonin Content of Rat Brain | Q51117135 | ||
Increase of morphine-induced analgesia by stimulation of the nucleus raphe dorsalis | Q51117757 | ||
Increase of Cerebral Catecholamines caused by 3,4-Dihydroxyphenylalanine after Inhibition of Peripheral Decarboxylase | Q51208477 | ||
Serotonin: Release in the Forebrain by Stimulation of Midbrain Raphé | Q51214792 | ||
Effect of dietary phenylalanine and tryptophan on brain serotonin. | Q51295672 | ||
The lateral hypothalamic syndrome: recovery of feeding and drinking after lateral hypothalamic lesions. | Q51296223 | ||
Effects of discrete brainstem lesions in cats on perception of noxious stimulation. | Q51320358 | ||
The effects of scopolamine and pilocarpine upon the aversive threshold of the rat. | Q52321131 | ||
The effect of para-chlorophenylalanine on aversion thresholds and reactivity to foot shock. | Q52326761 | ||
The effect of lowering the 5-hydroxytryptamine content of the rat spinal cord on analgesia produced by morphine. | Q54476149 | ||
Analgesia induced in vivo by central administration of enkephalin in rat | Q59061755 | ||
Antinociceptive action of quipazine: Relation to central serotonergic receptor stimulation | Q62782570 | ||
The cholinergic system and nociception in the primate: Interactions with morphine | Q66684689 | ||
5-hydroxytryptamine supersensitivity as a new theory of headache and central pain: a clinical pharmacological approach with p-chlorophenylalanine | Q68508962 | ||
Peripheral serotonin antagonists: failure to antagonize serotonin in brain areas receiving a prominent serotonergic input | Q68704070 | ||
Effect of 6-hydroxydopamine, 5,6-dihydroxytryptamine and raphe lesions on the antinociceptive actions of morphine in rats | Q69283651 | ||
Decreased antinociceptive activity of morphine in rats pretreated intraventricularly with 5,6-dihydroxytryptamine, a long-lasting selective depletor of brain serotonin | Q69622475 | ||
Effect of midbrain raphe lesion on the antinociceptive action of morphine and other analgesics in rats | Q69652873 | ||
Quipazine, a new type of antidepressant agent | Q71815817 | ||
The effects of p-chlorophenylalanine, a serotonin depletor, on avoidance acquisition, pain sensitivity and related behavior in the rat | Q71994600 | ||
Antagonism of the analgesic effect of morphine and other drugs by p-chlorophenylalanine, a serotonin depletor | Q72049939 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | serotonin | Q167934 |
neurology | Q83042 | ||
Anesthesiology and pain medicine | Q26842311 | ||
P304 | page(s) | 1-21 | |
P577 | publication date | 1977-10-01 | |
P1433 | published in | Pain | Q2317902 |
P1476 | title | Serotonin-containing neurons: their possible role in pain and analgesia | |
P478 | volume | 4 |
Q60682032 | 2c The antidepressant-induced analgesic effect |
Q39504156 | A controlled double blind study comparing the effects of strong Burst Mode TENS and High Rate TENS on painful osteoarthritic knees |
Q39574877 | A double-blind controlled study of a serotonin uptake inhibitor (Zimelidine) versus placebo in chronic pain patients |
Q44461609 | Abnormal 5-HT1D receptor function in cluster headache: a neuroendocrine study with sumatriptan |
Q40857165 | Action of selected serotonin antagonists on hyperthermia evoked by intracerebrally injected β-endorphin |
Q44428971 | Adenosine receptor agonists or antagonists alter antinociception, but did not show an interaction with imipramine-induced antinociception in the formalin test in mice |
Q28298267 | Advances in Perioperative Pain Management: Use of Medications with Dual Analgesic Mechanisms, Tramadol & Tapentadol |
Q41638462 | Afferent connections of the rostral medulla of the cat: a neural substrate for midbrain-medullary interactions in the modulation of pain |
Q49127113 | Alpha-Adrenergic and 5-hydroxytryptaminergic receptor stimulants as new antihypertensive drugs, with observations on involvement of opiate receptors |
Q72815936 | Analgesia induced by brief or more prolonged stress differs in its dependency on naloxone, 5-hydroxytryptamine and previous testing of analgesia |
Q40269412 | Analgesic effects of N-acetyl-5HTP-5HTP amide are not directly related to brain serotonin levels |
Q42391420 | Anti-nociceptive effect of tricyclic anti-depressants following intrathecal administration |
Q30962697 | Antibodies as molecular probes in neurobiology. Identification of chemically defined neurons and synapses in tissues and tissue cultures |
Q35044020 | Antidepressants for chronic neuropathic pain |
Q43562038 | Antinociceptive effect of clomipramine in monoarthritic rats as revealed by the paw pressure test and the C-fiber-evoked reflex |
Q52177696 | Aryl acylamidase activity exhibited by butyrylcholinesterase is higher in chick than in horse, but much lower than in fetal calf serum. |
Q71265546 | Aspirin analgesia evaluated by event-related potentials in man: possible central action in brain |
Q42632983 | Attenuation of pethidine-induced antinociception by zimelidine, an inhibitor of 5-hydroxytryptamine reuptake |
Q47684797 | Behavioral and neurochemical alterations following intracerebroventricular administration of anti-serotonin antibodies in adult Balb/c mice |
Q39776034 | Behavioral effects of serotonin neurotoxins: an overview |
Q35952007 | Behavioral impairments and serotonin reductions in rats after chronic L-dopa |
Q72733273 | Biochemical and immunohistochemical determination of 5-hydroxytryptamine located in mast cells in the trigeminal ganglion of the rat and guinea pig |
Q40085145 | Biological Perspectives in Chronic Pain, Depression, and Organic Mental Disorders |
Q41029289 | Changes in brain and spinal tryptophan and 5-hydroxy-indoleacetic acid levels follwing acute morphine administration in normal and arthritic rats |
Q54136926 | Changes in central serotoninergic transmission affect clonidine analgesia in monkeys. |
Q39571867 | Changes in endorphins and 5-hydroxyindoleacetic acid in cerebrospinal fluid as a result of treatment with a serotonin reuptake inhibitor (zimelidine) in chronic pain patients |
Q40123382 | Chronic pain: principles of management |
Q37223053 | Clinical and Pharmacological Review of the Efficacy of Orphenadrine and Its Combination with Paracetamol in Painful Conditions |
Q58830771 | Communications |
Q44187276 | Decreased sensitivity of 5-HT1D receptors in chronic tension-type headache |
Q72653382 | Descending Control of Pain Transmission: Possible Serotonergic-Enkephalinergic Interactions |
Q48704979 | Descending serotonergic, peptidergic and cholinergic pathways from the raphe nuclei: A multiple transmitter complex |
Q70357102 | Development of tolerance to the antinociceptive effect of metergoline |
Q71660322 | Distribution of neuropeptide FF in porcine spinal cord in comparison with other neuropeptides and serotonin |
Q48880536 | Dorsal Raphe Nucleus Modulates Sensory Evoked Responses in Caudate and Septum |
Q48476064 | Drug and environmentally induced manipulations of the opiate and serotonergic systems alter nociception in neonatal rat pups |
Q39253190 | Effect of depletion of rat brain 5-hydroxytryptamine on morphine-induced antinociception |
Q37050150 | Effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) and quipazine on heroin self-administration in rhesus monkeys |
Q52101107 | Effects of Moderate and High Doses of Marihuana on Thermal Pain: A Sensory Decision Theory Analysis |
Q73883924 | Effects of clomipramine and desipramine on a C-fiber reflex in rats |
Q30498540 | Effects of graded oral doses of a new 5-hydroxytryptamine/noradrenaline uptake inhibitor (Ro 15-8081) in comparison with 60 mg codeine and placebo on experimentally induced pain and side effect profile in healthy men. |
Q48213993 | Effects of pain-attenuating brain stimulation and morphine on electrical activity in the raphe nuclei of the awake rat |
Q48589308 | Effects of serotonin depleters on the contents of β-endorphin, α-melanotropin and adrenocorticotropin in rat brain and pituitary |
Q48846975 | Electrophysiological Evidence of Concurrent Dorsal Raphe Input to Caudate, Septum, Habenula, Thalamus Hippocampus, Cerebellum and Olfactory Bulb |
Q40196606 | Electrophysiological indices of opiate action in awake and anesthetized rats |
Q34188796 | Endogenous pain control mechanisms: Review and hypothesis |
Q40138938 | Endorphins and Pain |
Q41160125 | Evidence for enkephalin immunoreactive neurons in the medulla oblongata projecting to the spinal cord |
Q72527923 | Evidence that m-chlorophenylpiperazine inhibits some nociceptive responses of rats by activating 5-hydroxytryptamine mechanisms |
Q51861550 | Failure of narcotic antagonist to alter electroacupuncture modification of halothane anaesthesia in the dog. |
Q46092349 | Functional change of the auditory cortex related to brain serotonergic neurotransmission in type 1 diabetic adolescents with and without depression |
Q39454332 | Functional response of multiple opioid systems to chronic arthritic pain in the rat. |
Q52034346 | Hemi-field pattern reversal visual evoked potentials in migraine. |
Q70097484 | Hypothalamic monoaminergic mechanisms of aspirin-induced analgesia in monkeys |
Q49160500 | Identification and somatotopic organization of nuclei projecting via the dorsolateral funiculus in rats: A retrograde tracing study using HRP slow-release gels |
Q68182238 | Idiopathic genital pain and fluvoxamine |
Q40599206 | Idiopathic pain and depression |
Q38004437 | Imaging the serotonergic system by positron emission tomography |
Q40936846 | Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system |
Q72514344 | In vitro biochemical effects of nefopam hydrochloride, a new analgesic agent |
Q64967341 | In vivo microdialysis and in vitro HPLC analysis of the impact of paeoniflorin on the monoamine levels and their metabolites in the rodent brain. |
Q72917626 | Influence of naloxone and methysergide on the analgesic effect of clomipramine in rats |
Q49092960 | Injection of 5,7-dihydroxytryptamine into the B3 raphe region of neonatal rat pups induces hyperalgesia but only slight alterations in ingestion-related behaviors |
Q39557058 | Interactions between cardiovascular and pain regulatory systems |
Q72710316 | Intrathecal serotonin in mice: Analgesia and inhibition of a spinal action of substance P |
Q42448291 | Intraventricular capsaicin: Alterations in analgesic responsivity without depletion of substance P |
Q39535269 | Intraventricular morphine produces pain relief, hypothermia, hyperglycaemia and increased prolactin and growth hormone levels in patients with cancer pain |
Q48853840 | Involvement of biogenic amines with the mechanisms of novel analgesics |
Q60050302 | Involvement of spinal serotonergic pathways in nociception but not in avoidance learning |
Q42634761 | Involvement of the median raphe nucleus in antinociception induced by morphine, buprenorphine and tilidine in the rat. |
Q41540813 | L-tryptophan's effects on mouse killing, feeding, drinking, locomotion, and brain serotonin |
Q45057723 | Long-term effects of fluoxetine or vehicle administration during pregnancy on behavioral outcomes in guinea pig offspring |
Q38670761 | Mechanisms of the analgesic effect of calcitonin on chronic pain by alteration of receptor or channel expression |
Q60682056 | Meta-analysis of 38 placebo-controlled studies examining the antidepressant-induced analgesic effect |
Q41572234 | Metergoline elevates or reduces nociceptive thresholds in mice depending on test method and route of administration |
Q71804442 | Monoamines as mediators of the antinociceptive effect of baclofen |
Q48393969 | Morphine induces an increase in extracellular serotonin in the rat diencephalon |
Q70899790 | N-Acetyl groups and analgesia |
Q39738302 | Neuropharmacological and neuroendocrine substrates of stress-induced analgesia |
Q34441055 | Neurotensin and the serotonergic system |
Q40168435 | Nutrition and the neurosurgical patient |
Q48924725 | On strategies for identifying neurochemical correlates of hypnotic analgesia: a brief communication |
Q43762489 | On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor |
Q40066941 | On the role of 5-hydroxytryptamine in drug-induced antinociception |
Q49103952 | Organization of descending serotonergic projections to the spinal cord |
Q72745945 | Pain as a symptom in depressive disorders and its relationship to platelet monoamine oxidase activity |
Q44352718 | Pain sensitivity and opioid activity in genetically and experimentally hypertensive rats |
Q52294783 | Pharmacological studies on stimulation-produced analgesia in mice |
Q40098738 | Pharmacology of Pain and Analgesia |
Q44729117 | Pirenperone does not attenuate morphine analgesia in spinal rats |
Q69227597 | Platelet MAO in patients with idiopathic pain disorders |
Q48622412 | Possible involvement of serotonergic neurotransmission in neurotensin but not morphine analgesia |
Q72809995 | Possible role of central serotoninergic neurons in the development of dental pain and aspirin-induced analgesia in the monkey |
Q39506567 | Postoperative pain treated by intravenous l-tryptophan: a double-blind study versus placebo in cholecystectomized patients |
Q48710545 | Preparation of 8-[3-(4-fluorobenzoyl)-propyl]-1-(4-[123I] iodobenzoyl)-1,3,8-triazaspiro[4,5]decan-4-one: a novel selective serotonin 5-HT2 receptor agent |
Q72844425 | Prolonged depression of spinal transmission of nociceptive information by 5-HT administered in the substantia gelatinosa: antagonism by methysergide |
Q51868136 | Properties of the optical isomers and metabolites of ketamine on the high affinity transport and catabolism of monoamines |
Q39674189 | Psychological aspects of chronic pain |
Q43802150 | Psychotropic agents in the management of chronic pain |
Q72596837 | Psychotropic drugs |
Q40619856 | Recognition and treatment of patients with chronic orofacial pain |
Q48653402 | Reductions in pain thresholds and morphine analgesia following intracerebroventricular parachlorophenylalanine |
Q72606999 | Relationships between CSF levels of endorphins and monoamine metabolites in chronic pain patients |
Q51872352 | Reversible inactivation of raphe magnus neurons: effects on nociceptive threshold and morphine-induced analgesia |
Q57487919 | Review. Clomipramine in acute and chronic pain syndromes |
Q37653745 | Role of the Lateral Habenula in Pain-Associated Depression. |
Q69833758 | Serotonergic and opiate interactions in the modulation of drug- and environmental-induced analgesia in the neonatal rat pup |
Q38004446 | Serotonergic control of cerebral activity and behavior: models of dementia |
Q72903939 | Serotonergic mediation of descending inhibition from midbrain periaqueductal gray, but not reticular formation, of spinal nociceptive transmission in the cat |
Q48945362 | Serotonergic projections to the caudal brain stem: a double label study using horseradish peroxidase and serotonin immunocytochemistry |
Q48702708 | Serotonin concentrations in normal aging human brains: Relation to serotonin receptors |
Q48146541 | Serotonin immunocytochemistry of physiologically characterized raphe magnus neurons |
Q48600573 | Serotonin-containing projections to the thalamus in the rat revealed by a horseradish peroxidase and peroxidase antiperoxidase double-staining technique |
Q36391713 | Serotonin-induced hypersensitivity via inhibition of catechol O-methyltransferase activity |
Q68093388 | Serotonin-like immunoreactivity in the cat trigeminal ganglion |
Q72699114 | Similar behavioural effects of 5-hydroxytryptamine and substance P injected intrathecally in mice |
Q44352180 | Some perspectives on monoamine-opioid peptide interaction in rat central nervous system |
Q44352149 | Stereospecific inhibition of oxotremorine-induced antinociception by (+)-isomers of opioid antagonists: comparison with opioid receptor agonists |
Q72596893 | Stress analgesia: Effects of PCPA, yohimbine, and naloxone |
Q48190709 | Striatal neurochemistry of dynorphin-(1-13): in vivo electrochemical semidifferential analyses |
Q71709704 | Supramedullary afferents of the nucleus raphe magnus in the rat: a study using the transcannula HRP gel and autoradiographic techniques |
Q48087644 | Supraspinal nocifensive responses of cats: spinal cord pathways, monoamines, and modulation |
Q41561634 | Synergistic behavioral effects of serotonin and tryptamine injected intrathecally in mice |
Q60050318 | Test-specific effects of the 5-HT reuptake inhibitors alaproclate and zimelidine on pain sensitivity and morphine analgesia |
Q39577093 | The Emotion of Pain and its Chemistry |
Q48415887 | The antinociceptive effect of intracerebroventricularly administered prostaglandin D2 in the rat. |
Q39651799 | The antinociceptive effect of intracerebroventricularly administered prostaglandin E1 in the rat |
Q51252214 | The effect of IV L-tryptophan on prolactin, growth hormone, and mood in healthy subjects. |
Q49090272 | The effect of intravenous L-tryptophan on prolactin and growth hormone and mood in healthy subjects |
Q48643816 | The effect of modification of 5-hydroxytryptamine function in nucleus raphe magnus on nociceptive threshold |
Q71329285 | The effect of morphine on 5-hydroxytryptamine and catecholamine neurons in the rat brain. Histofluorescence studies |
Q49119355 | The effects of monoamine neurotoxins on peptides in the rat spinal cord |
Q66939825 | The effects ofL-DOPA on dorsal horn cell responses to innocuous skin stimulation |
Q70788994 | The identification of serotonergic neurons in the nucleus raphe magnus by conduction velocity |
Q42257076 | The influence of 5-HT receptor blocking agents on the behavioral effects of analgesics in rats |
Q39108615 | The role of neurotransmitters in stress-induced antinociception (SIA) |
Q36602436 | The ultrastructure and synaptic connections of serotonin-immunoreactive terminals in spinal laminae I and II. |
Q30498636 | Therapeutic implications of modifying endogenous serotonergic analgesic systems. |
Q70804969 | Time-course of alterations in morphine-induced analgesia and nociceptive threshold following medullary raphe lesions |
Q41539732 | Total and free serum tryptophan levels and brain 5-hydroxytryptamine metabolism in arthritic rats |
Q48952229 | Transmitters of the raphe-spinal complex: Immunocytochemical studies |
Q48206538 | Tryptophan and 5-hydroxyindoles in different CNS regions following acute morphine |
Q72605059 | Ultrastructural characterization of axonal endings in the substantia gelatinosa which take up [3H]serotonin |
Q38150274 | Vascular headaches and cerebral circulation: an overview |
Q72892347 | beta-Endorphin-induced release of 5-hydroxytryptamine from human platelets |
Q72555681 | p-Chlorophenylalanine antagonism of the analgesia and increase in brain noradrenaline metabolism produced by morphine |
Search more.